ABSTRACT
Non-syndromic orofacial clefts (NSOC) are common craniofacial birth defects, and result from both genetic and environmental factors. NSOC include three major sub-phenotypes: non-syndromic cleft lip with palate (NSCLP), non-syndromic cleft lip only (NSCLO) and non-syndromic cleft palate only (NSCPO), NSCLP and NSCLO are also sometimes grouped as non-syndromic cleft lip with or without cleft palate (NSCL/P) based on epidemiology. Currently known loci only explain a limited proportion of the heritability of NSOC. Further, differences in genetic susceptibility among the sub-phenotypes are poorly characterized. We performed a multi-ancestry GWAS meta-analysis on 44,094 individuals (9,381 cases, 28,510 controls, 2042 case-parent trios and 18 multiplex pedigrees) of East Asian, European, Latin and South American, and African ancestry for both NSOC and subtypes. We identified 50 loci, including 11 novel loci: four loci (CALD1, SHH, NRG1 and LINC00320) associated with both NSOC and NSCL/P, two loci (NTRK1 and RUNX1) only associated with NSOC, four loci (HMGCR, PRICKLE1, SOX9 and MYH9) only associated with NSCL/P and one locus (ALX1) specifically associated with NSCLO. Five of the novel loci are located in regions containing genes associated with syndromic orofacial clefts (SHH, NTRK1, CALD1, ALX1 and SOX9); seven of the novel loci are located in regions containing genes–implicated in craniofacial development (HMGCR, SHH, PRICKLE1, ALX1, SOX9, RUNX1, MYH9). Genetic correlation and colocalization analyses revealed an overlap between signals associated with NSCLO, NSCPO and NSCLP, but there were also notable differences, emphasizing the complexity of common and distinct genetic processes affecting lip and palate development.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was supported by the National Science Funds of China (No.81271118, No. 81600849), Sichuan Province Science and Technology support program (No.2024NSFSC0649), the Research and Develop Program, West China Hospital of Stomatology Sichuan University (No. RD-03-202301); R.M.F. was supported by a Wellcome Senior Fellowship (WT220390). This research was funded in part, by the Wellcome Trust [Grant number WT220390]. For the purpose of open access, the authors have applied a CC BY public copyright licence to any author accepted manuscript version arising from this submission; Liangdan Sun was supported by Hebei Natural Science Foundation H2023209084 and S&T Program of Hebei 23372505D; Miao He was supported by the Joint Funds of the National Natural Science Foundation of China (No. U22A20313); Yongchu Pan was supported by the National Natural Science Foundation of China (82270496) and Key Research and Development Program of Jiangsu Province (BE2023831); Zhuan Bian was supported by the National Natural Science Foundation of China (No.82170944, No.81970923, No.82370966)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional review boards of Sichuan University,Anhui Medical University,Wuhan University,Nanjing Medical University,University of Pittsburgh,University of Iowa,University of Lagos and Kwame Nkurumah University gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵# Senior authors
Data Availability
All results produced in the present study are available upon reasonable request to the authors
